Free Trial

Orchestra BioMed (OBIO) Institutional Ownership

Orchestra BioMed logo
$2.90 +0.02 (+0.52%)
As of 07/3/2025 02:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)

Current
Institutional Ownership
Percentage
53.55%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$16.60M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$389.18K
Get OBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

OBIO Institutional Buying and Selling by Quarter

Orchestra BioMed Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/16/2025Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127%
5/13/2025HighTower Advisors LLC61,000$261K0.0%-10.9%0.159%
5/12/2025Nuveen LLC41,729$179K0.0%N/A0.109%
5/9/2025Deutsche Bank AG20,219$87K0.0%+67.3%0.053%
5/5/2025IFP Advisors Inc161,921$693K0.0%+106.4%0.423%
2/17/2025Millennium Management LLC21,513$86K0.0%N/A0.057%
2/17/2025Citadel Advisors LLC12,279$49K0.0%-39.0%0.032%
2/17/2025Bank of America Corp DE23,780$95K0.0%+42.0%0.063%
2/14/2025Boxer Capital Management LLC238,193$953K0.1%N/A0.627%
2/14/2025Northern Trust Corp236,761$947K0.0%+2.5%0.623%
2/14/2025The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097%
2/14/2025Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282%
2/13/2025Barclays PLC37,786$152K0.0%+18.9%0.099%
2/13/2025Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035%
2/12/2025Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506%
2/12/2025JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130%
2/7/2025HighTower Advisors LLC68,500$274K0.0%+34.3%0.180%
1/17/2025SG Americas Securities LLC12,785$51K0.0%+26.0%0.034%
11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032%
11/19/2024Barclays PLC31,785$163K0.0%+281.3%0.084%
11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492%
11/15/2024Barclays PLC31,785$163K0.0%+281.3%0.084%
11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050%
11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130%
11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587%
11/13/2024The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088%
11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574%
11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035%
10/3/2024SG Americas Securities LLC10,143$52K0.0%N/A0.028%
8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056%
8/15/2024The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118%
8/1/2024Rhumbline Advisers26,439$215K0.0%+192.7%0.074%
7/26/2024Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197%
5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%
5/11/2024Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062%
2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%
10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%
10/27/2023TD Asset Management Inc92,678$808K0.0%+100.0%0.259%
10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113%
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009%
10/13/2023Arkadios Wealth Advisors51,595$450K0.0%N/A0.144%
8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%
8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181%
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%
5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652%
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%
(Data available from 1/1/2016 forward)

OBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OBIO shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Geode Capital Management LLC ($2.29M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), and Boxer Capital Management LLC ($953K).Learn more on Orchestra BioMed's institutional investors.

What percentage of Orchestra BioMed's stock is owned by institutional investors?

53.55% of Orchestra BioMed's stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings.

Which institutional investors have been buying Orchestra BioMed's stock?

Of the 27 institutional investors that purchased Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K).

How much institutional buying is happening at Orchestra BioMed?

Institutional investors have bought a total of 3,284,340 shares in the last 24 months. This purchase volume represents approximately $16.60M in transactions.

Which of Orchestra BioMed's major shareholders have been selling company stock?

The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Goldman Sachs Group Inc. ($26.82K), Price T Rowe Associates Inc. MD ($25.49K), The Manufacturers Life Insurance Company ($8.78K), Citadel Advisors LLC ($7.84K), SkyView Investment Advisors LLC ($7.72K), HighTower Advisors LLC ($7.50K), and Jane Street Group LLC ($4.71K).

How much institutional selling is happening at Orchestra BioMed?

Institutional investors have sold a total of 88,850 shares in the last 24 months. This volume of shares sold represents approximately $389.18K in transactions.



This page (NASDAQ:OBIO) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners